| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 295,694 | 186,193 | ||
| Restricted cash | 5,000 | 5,000 | ||
| Marketable securities | 814,055 | 610,831 | ||
| Trade receivables, net | 113,285 | 79,231 | ||
| Inventory | 69,317 | 63,497 | ||
| Prepaid expenses and other current assets | 49,329 | 58,604 | ||
| Total current assets | 1,346,680 | 1,003,356 | ||
| Property and equipment, net | 2,913 | 1,615 | ||
| Intangible assets, net | 7,477 | 4,548 | ||
| Right-of-use asset | 5,387 | 5,862 | ||
| Total assets | 1,362,457 | 1,015,381 | ||
| Accounts payable | 44,941 | 37,975 | ||
| Accrued liabilities | 345,382 | 157,479 | ||
| Lease liability | 1,083 | 1,049 | ||
| Total current liabilities | 391,406 | 196,503 | ||
| Loan payable, net of discount | 339,753 | 118,376 | ||
| Lease liability | 5,566 | 4,524 | ||
| Total long term liabilities | 345,319 | 122,900 | ||
| Total liabilities | 736,725 | 319,403 | ||
| Common stock, par value 0.0001 per share authorized 200,000,000 at september30, 2025 and december31, 2024 22,704,303 and 22,004,679 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 2 | 2 | ||
| Additional paid-in-capital | 2,656,553 | 2,612,566 | ||
| Accumulated other comprehensive income | 1,068 | 1,111 | ||
| Accumulated deficit | -2,031,891 | -1,917,701 | ||
| Total stockholders equity | 625,732 | 695,978 | ||
| Total liabilities and stockholders equity | 1,362,457 | 1,015,381 | ||
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)